MASI
Masimo CorpPrice & Indicators
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Shipments of noninvasive technology boards and instruments | 270K | Full-Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MASI
this stock
Masimo Corp
|
$9.42B | +38.4% | +8.3% | 127.6 | 6.7% |
|
ABT
Abbott Laboratories
|
$154.67B | -28.4% | +5.7% | 24.9 | 1.3% |
|
SYK
Stryker Corp
|
$120.24B | -9.7% | +11.2% | 36.3 | 1.8% |
|
MDT
Medtronic plc
|
$102.89B | -15.5% | +8.4% | 21.6 | 1.5% |
|
BSX
Boston Scientific Corp
|
$64.07B | -54.9% | +5.5% | 18.0 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MASI | +0.6% | +0.9% | +31.7% | +0.8% | +38.4% |
| SPY | +0.6% | -0.9% | +9.7% | -2.0% | +8.8% |
| vs SPY | +0.1% | +1.8% | +22.0% | +2.8% | +29.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.